About
Technology
Issues
FAQ
Links
Official Page
Clinical similarity of the biosimilar ABP 501 compared with adalimumab after single transition: long-term results from a randomized controlled, double-blind, 52-week, phase III trial in patients with moderate-to-severe plaque psoriasis
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.